[1] |
LIANG Jie.
172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
|
[2] |
WANG Chunting, CHEN Yafei.
Considerations for Revision of Safety Information in the Post-Marketing Instructions of Chemical Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 776-779.
|
[3] |
ZHU Huijuan, REN Jingtian.
Safety Risks of Human Rabies Immunoglobulin
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 786-789.
|
[4] |
LIU Yiyu, LI Yanwen, WANG Jiao, ZHOU Wenjing, PENG Yumeng, HE Wenbin, LI Zhiyong.
Efficacy Semantic Mining and Safety Analysis of Chinese Patent Medicines for Headache
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 674-679.
|
[5] |
ZHANG Huiting, LI Youlin, LI Lei, YAN Yue, YAO Ting, LI Chunlei, SHI Qi.
Toxicity of Single-Dose and Repeated-Dose Administration of Guisha Zichuan Granules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 547-553.
|
[6] |
DI Ruiyi, XU Lu, YANG Jingfan, ZHU Lili, XUE Shujuan, CHEN Suiqing, SUN Xiaoya.
Morphology, Chemical Composition and Safety of Three Toxic Traditional Chinese Medicines
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 560-563.
|
[7] |
FAN Liping, LU Shu, SUN Huiyuan.
Efficacy and Safety of Panax Quinquefolium Saponin in Adjuvant Treatment of Angina Pectoris of Coronary Heart Disease: a Meta-Analysis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 570-574.
|
[8] |
WANG Fengxin, LI Lei, HUANG Xurui, ZHAO Yun, LING Ruby, YANG Yang, LIANG Changhao, ZENG Yuntao, ZHENG Yingjun, TANG Yuanchen, LIU Jiatao, WANG Chengxiang, WEN Tiancai, LI Ping.
Efficacy and Safety of Danshen Decoction in Treatment of Coronary Heart Disease
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 575-579.
|
[9] |
WU Shiqi, SU Su, YAN Suying, ZHANG Qingxia.
Bleeding Induced by Rivaroxaban Combined with PK-DDI in Patients with Nonvalvular Atrial Fibrillation and Renal Insufficiency:a Retrospective Cohort Study
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 415-419.
|
[10] |
ZHANG Yunhui, CHEN Haoyun, ZHONG Luhua, FANG Caifu, HUANG Huanjun, GUO Chenchen, DONG Xinyi, SHI Feng, LIANG Weiting.
159 Cases of Adverse Reactions to Immune Checkpoint Inhibitors
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 442-446.
|
[11] |
LUO Wen, WU Jing, HE Dake, YANG Rui.
One Case of Dermatitis Medicamentosa in a Paediatric Epilepsy Patient Caused by Lacosamide Oral Solution
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 452-455.
|
[12] |
GUO Dongqi, WANG Hao, BAI Xin, BAI Jianqi, SU Hongmei, ZHANG Jingru, GUO Xiaofei, ZHAO Xiaoqi, WANG Min, WANG Yuan, ZHANG Ping.
Identification of Druggable Targets for Intervertebral Disc Degeneration Based on Multi-Omics Data-Driven Mendelian Randomization and Prediction of Traditional Chinese Medicine Interventions
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 241-248.
|
[13] |
KANG Jiaqi, GUO Xiaofei, SU Hongmei, BAI Jianqi, ZHU Hongwei, BAI Xin, CHEN Xin, WANG Hao, ZHAO Xiaoqi, GUO Dongqi, WANG Yuan, ZHANG Ping.
Interventions of Bushen Huoxue Decoction in Lumbar Intervertebral Disc Degeneration of Kidney Deficiency and Blood Stasis Type in Rats
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 249-257.
|
[14] |
JIA Zhichao, HU Siyuan, LI Ruiben, XU Yaqian.
Safety of Children’s Traditional Chinese Medicine Decoction Pieces in Clinical Application and Children’s Drug Development
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 324-328.
|
[15] |
HU Kun, HUANG Weiguo, LEI Lili, PANG Xiaocong, ZHOU Ying, CUI Yimin.
One Case of Bone Marrow Suppression Caused by Azathioprine Tablets in a Patient with TPMT Heterozygous Mutation
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 337-340.
|